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Abstract: The aim of this article is to review the association between diabetes mellitus, 
cognitive decline and dementia, including the effects of cognitive decline and dementia on 
self management of diabetes. This is a literature review of primary research articles.  
A number of contemporary research articles that met the inclusion criteria were selected 
for this review paper. These articles were selected using a number of search strategies and 
electronic databases, such as EBSCOhost Research and SwetsWise databases. The duration 
of diabetes, glycated haemoglobin levels and glycaemic fluctuations were associated with 
cognitive decline and dementia. Similarly, hypoglycaemia was significantly related to 
increased risk of developing cognitive decline and dementia. Furthermore, cognitive 
decline and dementia were associated with poorer diabetes management. There is evidence of 
the association between diabetes, cognitive decline and dementia including the shared 
pathogenesis between diabetes and Alzheimer’s disease. In addition, the self management 
of diabetes is affected by dementia and cognitive decline. It could be suggested that the 
association between diabetes and dementia is bidirectional with the potential to proceed to 
a vicious cycle. Further studies are needed in order to fully establish the relationship 
between diabetes, cognitive decline and dementia. Patients who have diabetes and 
dementia could benefit from structured education strategies, which should involve 
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empowerment programmes and lifestyle changes. The detection of cognitive decline 
should highlight the need for education strategies. 
Keywords: diabetes; dementia; Alzheimer’s disease; cognitive decline; lifestyle 
interventions; self-management of diabetes; diabetes complications 
 
1. Introduction 
Diabetes Mellitus (DM) is a metabolic disorder that results from beta cell dysfunction and/or the 
failure of insulin to exert its biological influence at the level of the muscle or the liver, thus leading to 
chronic hyperglycaemia [1]. Diabetes often involves disturbances of carbohydrate, fat and protein 
metabolism with severe ramifications resulting in long term complications. These complications 
impact on the physiological systems and organs of the body and may lead to cerebrovascular 
dysfunction and dementia. The prevalence of Diabetes is on the increase in both the UK and 
worldwide partly due to advances in technology which enable more effective and better diagnosis, 
lifestyle choices and an ageing population [1,2]. 
On the other hand, dementia is the most severe pathological form of brain ageing [3].  
All dementias, including Alzheimer’s disease, Vascular dementia, Frontal—temporal and Lew body 
dementia, involve a progressive decline in multiple areas of higher cortical function, including 
memory, reasoning, communication, and ability to carry out activities of daily living [4,5]. Alongside 
this decline, individuals may experience behavioural and psychological symptoms, such as depression, 
aggression, psychosis, and wandering [6]. The prevalence of dementia is also on the increase both in 
the UK and worldwide, again, partly due to the ageing population [7]. 
1.1. Prevalence of Diabetes and Dementia 
The worldwide prevalence of diabetes is estimated to be 285 million adults, with this number expected 
to rise to 439 million in 2030 [8]. However, type 2 diabetes may be present in up to 80% of individuals 
with dementia who are aged 65 years or older [9]. Type 2 diabetes may increase the risk of developing 
Alzheimer’s disease from the “pre-dementia” condition of mild cognitive impairment [9,10]. 
Globally, 35.6 million people are living with dementia, with this number projected to double every 
20 years [8,9]. In the UK 700,000 people are estimated to have dementia and this figure is expected to 
rise to over 1.7 million by 2051 [4], with one in 14 people over the age of 65 years and one in six over 
the age of 80 years living with dementia [3]. 
Risk factors for dementia include age and genetic predisposition [11]. In addition, the association 
between glucose, insulin and lipid metabolism and the underlying neurobiological changes observed in 
patients with Alzheimer’s disease are being established (Box 1). Longitudinal prospective studies 
support the link between type 2 diabetes and hyperinsulinaemia with the development of Alzheimer’s 
disease, however not all research confirms this relationship [10]. 
In recent years, the role of diabetes in the development of cognitive decline and dementia has been 
the subject of research studies and discussion [10,12]. Box 1 shows the relationships between key 
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factors including hyperglycaemia, hyperinsulinaemia and comorbid vascular conditions, which are 
associated with diabetes and other metabolic pathways that link diabetes to Alzheimer’s disease [10]. 
Interestingly, concerns remain with respect to the possible impact of cognitive impairment and 
memory loss on the self management of diabetes. Self-management of diabetes is the ability of the 
individual with diabetes to make choices and decisions about their lives and how they manage their 
condition [13]. This is aimed at improving the quality of their lives and reducing the risk of developing 
complications. While self management is the process of developing appropriate skills by individuals 
with diabetes to manage their condition, self care relates to the daily activities carried out to control the 
disease [13]. Some of the essential components of self management related to diabetes care include 
managing acute complications such as hypoglycaemia and hyperglycaemia, managing associations 
between food, physical activity and medications, and self monitoring of blood glucose and blood 
pressure [14]. In addition, persons with diabetes need support from health care professionals, peers, 
family, friends and carers, and access to structured education, personalised care plan, and emotional 
and psychological support in order to promote self management [13]. 
Box 1. Key elements and metabolic pathways linking Type 2 diabetes and  
Alzheimer’s disease. 
Hyperglycaemia 
Hyperinsulinaemia 
Comorbid Vascular Conditions (Hypertension, Obesity) 
Dyslipidaemia (High triglycerides, Low High density lipoprotein cholesterol, Dense Low density 
lipoprotein particles) 
Cerebrovascular dysregulation (Endothelial dysfunction, Microinfarcts, White matter changes)  
Amyloid – β metabolism (Amyloid – β generation, Reduced Amyloid – β clearance) 
Inflammation 
Source: [10] 
Therefore, a review of the possible impact of diabetes on cognitive impairment and the consequence of 
this on the management of diabetes and associated complications becomes pertinent. The effect of diabetes 
on cognitive impairment may result from the physiological changes associated with diabetes and the role of 
poor glucose control which may lead to chronic hyperglycaemia and hypoglycaemia [14–17]. In addition, 
the reverse impact of dementia on diabetes appears to complete this cycle of relationships which could 
be defined as a bidirectional model. Within this article, the terms cognitive impairment and cognitive 
decline are used interchangeably. 
1.2. Aim 
This article is a literature review of published research studies. The aim is to evaluate the 
bidirectional association between diabetes, cognitive decline and dementia. 
2. Methods 
A review was carried out based on published guidelines [18]. The literature search involved 
relevant articles relating to diabetes, cognitive decline, dementia, and self- management of diabetes. 
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An initial general scoping of the databases on the risk of developing dementia from diabetes found the 
Rotterdam study [19] and some systematic reviews [20,21]. Since these publications, a number of 
other primary research studies have been conducted. 
The following data bases which included EBSCO Host/Health Sciences Research databases 
(encompassing Academic search premier, Medline, Psychology and Behavioural sciences collection, 
PSYCINFO, SPORTDISCUSS and Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) Plus) and SwetsWise were searched. In addition, reference lists of identified articles were 
manually searched for relevant studies. 
2.1. Inclusion and Exclusion Criteria 
Primary research articles which are usually based on original and/or new data, published between 
2004 and 2014 and written in English language were the only studies included in this review.  
Although Biessels et al. [20] published a systematic review in 2006, the year of publication for articles 
included in the current review commenced in 2004 because relevant studies such as the article 
published by Beeri et al. [22] were omitted in that systematic review. 
In particular, while examining the associations between diabetes, cognitive impairment and 
dementia only longitudinal prospective studies were included, and cross sectional studies were selected 
to assess the possible effect of cognitive dysfunction on management of diabetes. Although 
longitudinal prospective studies may attempt to establish the link between diabetes and dementia, 
evidence of the role of dementia and cognitive impairment on diabetes are limited in this study design. 
Therefore, another type of research design in the form of cross sectional studies which provide this 
evidence were included in the review. Studies which did not meet the above inclusion criteria were 
excluded from the study. The outcome measures of interest were cognitive impairment, dementia,  
self-management of diabetes, hyperglycaemia, hypoglycaemia and glycated haemoglobin. 
2.2. Data Analysis 
Based on the key terms used for the search, 5538 articles were found initially. Of these articles, 
eleven articles which met the requirements for selection were included in the review (Table 1). 
3. Results 
3.1. Association between Diabetes, Cognitive Impairment and Dementia 
Eight [8,22–28] of the eleven studies included, investigated the risk of cognitive decline and 
dementia in patients with diabetes. Similar trends were observed in six of the eight studies with the 
main findings showing that diabetes, including its duration, glycated haemoglobin (HbA1c) levels and 
glycaemic fluctuations were associated with cognitive decline and dementia [8,22–26] although one of 
these studies [23] showed that cognitive decline may be less evident after age 85 years.  
The biochemical measures of diabetes are mainly defined by the levels of blood glucose (Fasting, 
Postprandial and glycated haemoglobin) [1]. Two of the studies that examined the relationship between 
hypoglycaemia and the risk of developing cognitive impairment and dementia found that hypoglycaemia 
was significantly associated with increased risk of cognitive decline and dementia [27,28]. 
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Table 1. Summary of Studies Reviewed. 
Citation Country Type of Study Sample size Aims/Objectives Outcomes 
Sanz et al., 2012 [8] France 
Prospective 
multicentre cohort 
study (Longitudinal) 
608 
To determine whether diabetes mellitus influences 
functional status in patients with Alzheimer’s disease. 
At baseline, the presence of diabetes significantly 
increases the risk of functional disability in patients 
with Alzheimer’s disease. 
Beeri et al.,  
2004 [22] 
Israel Longitudinal study 1892 
To examine the association between diabetes in midlife 
and dementia more than three decades later. 
There was evidence that diabetes was a risk factor  
for dementia. 
van den Berg et al., 
2006 [23] 
The Netherlands 
Prospective and 
longitudinal 
599 
To examine the impact of diabetes mellitus on 
cognitive decline over time in the oldest of the old. 
Very old patients with diabetes have lower cognitive 
function compared with patients without diabetes at 
age 85 years, but they do not decline faster at age 85 
years to 90years. 
Umegaki et al.,  
2012 [24] 
Japan Longitudinal study 63 
To identify the associated factors with  
cognitive decline. 
Higher glycaeted haemoglobim (HbA1c) had a 
tendency toward association with cognitive decline. 
Gao et al.,  
2008 [25] 
United Kingdom 
Multi-centre 
longitudinal study 
1139 
To investigate the association between the level of 
HbA1c and mortality from all causes, including 
cognitive decline. 
Respondents in the group HbA1c ≥7% who had not 
been diagnosed had a significantly higher risk of 
developing dementia.  
Biomarkers of glucose metabolism (HbA1c) are 
associated with dementia. 
Okereke et al.,  
2008 [26] 
USA 
Prospective cohort 
study (Longitudinal) 
12,233 
To relate diabetes mellitus status and duration to  
late-life cognitive impairment and decline. 
Type 2 diabetes and longer duration of diabetes are 
similarly related to cognitive impairment and decline 
Lin and Sheu,  
2013 [27] 
Taiwan Longitudinal study  15,404 
To investigate the risk of dementia in patients  
with type 2 diabetes with or without prior 
hypoglycemic episodes. 
Adult patients with prior hypoglycaemia had a 
significantly increased risk of dementia 
Feinkohl et al.,  
2014 [28] 
UK 
Prospective study 
(Longitudinal) 
831 
To determine the association of both prevalent and 
incident severe hypoglycaemia with cognitive decline. 
Severe hypoglycaemia was associated with significant 
decline in cognitive function.  
Lower cognitive ability at baseline was associated with 
two fold higher incidence of severe hypoglycaemia 
over 4 years 
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Table 1. Cont. 
Citation Country Type of Study Sample size Aims/Objectives Outcomes 
Feil et al., 2011 [29] USA 
Cross sectional 
database analysis 
497,900 
To examine the relationship between management of 
diabetes and hypoglycemia in older adults with and 
without dementia and cognitive impairment 
Dementia and cognitive impairment were 
independently associated with greater risk  
of hypoglycemia 
Feil et al., 2012 [30] USA 
Cross sectional 
observational analysis 
1398 
To examine the relationship between cognitive 
impairment and diabetes self management 
Cognitive impairment is associated with worse  
self care. 
Grober et al.,  
2011 [31] 
USA Cross sectional study 169 
To assess the relationship of glycemic control to 
memory impairment and executive dysfunction in older 
adults with diabetes 
Memory impairment and executive dysfunction were 
associated with inadequately controlled diabetes.  
Cognitive dysfunction may interfere with diabetes 
management and inadequate diabetic control may 
contribute to cognitive decline 
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In a study by Sanz et al. [8], the longitudinal data confirmed that diabetes was associated with 
functional disability in patients diagnosed with Alzheimer’s disease for less than one year, but not in 
those diagnosed with Alzheimer’s disease longer than one year. On the other hand, Beeri et al. [22] 
found that diabetes in mid life could be linked to dementia more than three decades later. 
The study by van den Berg et al. [23] showed that at 85 years of age, diabetes was associated with a 
lower level of cognitive functioning, while in another study [24], higher glycated haemoglobin was 
linked with cognitive decline. Gao et al. [25] revealed that the risk of developing dementia was 
significantly higher in those who have not been diagnosed with diabetes but with glycated 
haemoglobin equal to or higher than 7% and there is further evidence [26] linking type 2 diabetes and 
longer duration with cognitive impairment and decline. 
Lin and Sheu [27] found that in adults with diabetes who had prior in-hospital diagnosis of 
hypoglycaemia, the risk of developing dementia was almost three times more, while Feinkohl et al. [28] 
observed that severe hypoglycemia at baseline and during follow-up was associated with higher risk of 
cognitive decline. 
3.2. Effect of Dementia and Cognitive Decline on Self Management of Diabetes 
Three studies assessed the impact of dementia and cognitive decline on self-management of 
diabetes. The primary outcomes of these studies [29–31] were that, cognitive impairment and dementia 
were associated with hypoglycaemia, inadequate control of diabetes and worse self-care. One of these  
studies [29] reported that, cognitive impairment and dementia were independently associated with 
greater risk of hypoglycaemia. 
For example, Feil et al. [29] revealed that dementia and cognitive impairment were risk factors for 
hypoglycaemia particularly in patients who are on insulin. Further study [30] found significant 
association between cognition and diabetes self management. In addition, Grober et al. [31] showed 
that impairment in memory and executive dysfunction were associated with inadequate control of diabetes. 
4. Discussion 
Evidence from studies reviewed has shown that diabetes is a risk factor in the development of 
dementia which is often accompanied by a progressive decline in cognitive function. It is expected that 
patients with diabetes should be involved in the process of taking control and making decisions about 
aspects of their diabetic care which has been defined as diabetes self management [14]. However,  
a cognitive impairment may have repercussions for the patient with diabetes with potential for poor 
self management, leading to further complications including inadequate control of diabetes, 
hypoglycaemia and hyperglycaemia [27,28]. In addition, the processes and pathways linking diabetes 
to cognitive impairment and dementia are varied and involve the role of insulin and chronic 
hyperglycaemia. This association appears bidirectional and may proceed to a vicious cycle where 
diabetes could lead to dementia and dementia causing further complications of diabetes.  
This is possible because diabetes care involves self management and a decline in cognitive function in 
patients with diabetes and dementia may result in poor self management. Therefore, a poorly managed 
diabetes may exacerbate dementia and cognitive impairment through the possible effect of 
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hyperglycaemia and hypoglycemia. These bidirectional relationships are further discussed below under 
different subheadings and supported with evidence. 
4.1. The Association between Diabetes, Cognitive Decline and Dementia 
The papers reviewed [8,22–28] showed the association between diabetes, cognitive impairment and 
dementia. Epidemiological studies, such as the Rotterdam Study [19] and more recently the Hisayama 
Study [32] have also established the link between diabetes mellitus and the increased risk of 
developing dementia. Diabetes is a condition caused by multiple aetiology. While Type 1 diabetes 
results from autoimmune condition leading to pancreatic beta cell destruction and it is primarily of 
genetic origin, type 2 diabetes is influenced by both genetic and environmental factors, including poor 
dietary habits, age, ethnicity and lack of physical activity [1]. In type 2 diabetes, the gradual erosion of 
beta cell function leads to increased hyperglycaemia while the resistance to the action of insulin could 
lead to hyperinsulinaemia. A combination of beta cell dysfunction and/or insulin resistance may lead to 
chronic hyperglycaemia and glucose toxicity which have profound implications for the body, including 
the brain and therefore, cognition. The toxic effect of high glucose concentration found in patients with 
diabetes may have effect on the neurons in the brain through osmotic insults and oxidative stress,  
and continued chronic hyperglycaemia, which leads to the formation of advanced glycation end 
products (AGE) [33]. AGE coupled with free radicals can cause oxidative damage which can in turn 
lead to neuronal injury. 
In large-scale epidemiological studies, diabetes has been found to be a significant risk factor for age 
related cognitive impairment, cognitive decline and dementia [26]. The impact of diabetes on the 
vascular system may also contribute to cognitive impairment and dementia. 
The mechanism by which insulin affects memory may relate to a number of pathways. Firstly is the 
role of insulin in cerebral energy metabolism [34]. It is thought that insulin increases the translocation 
of GLUT4 (Glucose transporter), which is present in the brain [34]. Therefore, a dysfunction of the 
beta cell in diabetes can disrupt insulin secretion, reduce the level of insulin in the brain and may affect 
this mechanism thus leading to glucose dysregulation [33]. In addition, impaired insulin signalling 
found in diabetes could also affect this process causing a derangement of glucose metabolism which 
can impact on neuronal development, learning and memory [34]. 
The effect of type 2 diabetes, dislipidaemia and hyperinsulinaemia may lead to abnormal metabolism of 
amyloid-β, which is significant in the development of cerebrovascular dysfunction [10]. Furthermore, 
insulin has direct role in the metabolism of amyloid-β and the effect of abnormal glucose metablosim may 
lead to the production of AGEs which contribute to the development of diabetes and dementia [10]. 
Type 2 diabetes also contribute to cerebrovascular dysfunction through ischemia of the 
microvascular system and endothelial dysfunction leading to chronic cerebral hypoperfusion and these 
changes may affect regional cerebral blood flow that impairs cerebral protein synthesis, a key factor 
for learning and memory [10]. 
According to Umegaki et al. [33], the major functions of insulin in the brain are control of food 
intake and cognitive functioning such as memory; these are affected in insulin resistant states.  
For example, following insulin resistance and hyperinsulinaemia which are common features of type 2 
diabetes, the transport of insulin into the brain across the blood brain barrier is reduced and this lowers 
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the insulin levels in the brain [33]. Therefore, chronic peripheral hyperinsulinaemia may lower brain 
insulin levels and this could reduce insulin degrading enzyme levels in the brain thereby impairing 
amyloid—β clearance [34]. 
There is evidence of a shared pathogenesis between diabetes and Alzheimer’s disease which has been 
termed as Type 3 diabetes [35–38]. These links appear to centre around the acetylcholine, amyloid and tau, 
inflammation, mitochondria and oxidative stress and advanced glycation end products [10,20,34,37]. 
Insulin regulates the central nervous system levels of acetylcholine and norepinephrine, 
neurotransmitters which influence cognitive function [34]. It is clear that insulin plays a significant 
role in neurological function through its effect on choline acetyl transferase, an enzyme responsible for 
acetylcholine production [37]. Acetylcholine, a neurotransmitter is responsible for cognition and 
memory formation, thus, a dysfunction in insulin production and insulin resistance could lead to a 
decrease in acetylcholine levels which may have repercussions for cognition and memory [36]. 
The accumulation of amyloid beta protein in the brain and pancreatic islet cells is another  
evidence of the association between diabetes and Alzheimer’s disease and the similarity in their 
pathogenesis [26,36]. The common understanding of the progression of Alzheimer’s disease is that there is 
accumulation of neuro-fibrillary plague tangles among the brain neurons [35]. Often, these tangles result 
from the overproduction of beta-amyloid proteins which the body is unable to remove [35]. These  
beta-amyloid plagues create neurologic tangles that kill neurons, thus leading to decreased cognition [35]. 
In addition, the developments of diabetes and Alzheimer’s disease are related to increased oxidative 
stress and production of advanced glycation end products [36]. AGEs are formed as the end products 
of Maillard reaction when reducing sugars react non-enzymatically with amino groups of proteins [37].  
The metabolic consequences of AGEs include oxidative stress, hypometabolism, impaired cell 
function, modification of plagues and neurofibrillary tangles, the latter having been implicated in the 
development of Alzheimer’s disease [36,37]. 
4.2. The Role of Hypoglycaemia in the Development of Dementia 
According to Feinkohl et al. [28], severe hypoglycaemia was related to significant decline in 
cognitive function, while Lin and Sheu [27] found that adult participants with diabetes who had 
previous diagnosis of hypoglycaemia had an almost three-fold increased risk of developing dementia 
in the subsequent seven-year follow up compared with those without hypoglycaemia. An earlier study 
by Aung et al. [16] found that severe hypoglycaemia was associated with poorer late-life cognitive 
ability. Although the reasons for the association between hypoglycaemia and cognitive decline remain 
unclear, a possible explanation is that neuronal cell death may accelerate the process of cognitive decline 
and dementia by its effect on focal neurological deficits and transient ischaemic attacks [27,28].  
In addition, during episodes of hypoglycaemia, higher adrenaline levels increase platelet activation, 
leucocyte mobilisation, blood coagulability and impairment of endothelial function [27].  
In patients with type 1 diabetes, vessel wall stiffness was found to be greater during hypoglycaemia in 
patients with diabetes of longer duration than those with diabetes of shorter duration. 
While the above studies suggest that repeated exposure to severe hypoglycaemia resulted in 
cognitive impairment in people with diabetes, the prospective Epidemiology of Diabetes Interventions 
and Complications (EDIC) study showed no association between the frequency of severe 
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hypoglycaemia and cognition over the follow-up period of 18 years [39]. Feinkohl et al. [28] provided 
explanations for the differences observed including the fact that participants in the Diabetes 
Interventions and Complications Trial were selected because they were highly compliant with 
treatment and had low risk of hypoglycaemia. Therefore, the results in the EDIC study could have 
been limited by the low prevalence of hypoglycaemia and age-related cognitive decline. 
4.3. Impact of Dementia and Cognitive Impairment on Self Management of Diabetes 
The approaches to managing diabetes in patients with dementia could be preventative or involve the 
actual treatment of diabetes. These strategies may include interventions to increase insulin sensitivity, 
reduction of insulin levels, lifestyle interventions (diet and exercise), use of oral hypoglycaemic agents 
(metformin, sulfonylureas and thiazolidinediones) and insulin [40]. 
While peripheral hyperinsulinaemia contribute to the development of Alzheimer’s disease,  
the administration of intranasal insulin, which travels directly into the central nervous system,  
may enhance cognition in patients with early Alzheimer’s disease or Mild Cognitive Impairment [10]. 
Impairment in cognitive ability may affect the capacity of the patients with diabetes to take effective 
control of their condition and engage in the management strategies outlined above. The studies relating 
to the impact of dementia and cognitive decline on self-management of diabetes showed that cognitive 
decline and dementia were linked to hypoglycaemia, inadequate control of diabetes and worse  
self-care [16,27,28]. Conversely, hypoglycaemia has been shown to be associated with increased risk 
of cognitive impairment, further strengthening the bidirectional relationship between diabetes, 
cognitive decline and dementia [27,28]. 
According to Acee [9], diabetes self-management refers to the patient’s responsibility and 
involvement in almost all aspects of his or her diabetes care and management. However, patients with 
diabetes and declining cognitive function may present with difficulties in managing self-care [3], 
including failure to effectively administer their medications such as oral tablets and insulin, 
monitoring, adherence to diet and exercise regimes. These can lead to the development of diabetic 
complications including hypoglycaemia, hyperglycaemia, diabetic ketoacidosis and hyper osmolar non 
ketotic state. Impairment in language, confusion and disorientation are common symptoms of dementia 
and hypoglycaemia and these similarities in symptoms can affect diagnosis and management of these 
conditions [3]. Similarly, discomfort or pain has been shown to be difficult to express in people with 
dementia and this is not uncommon in diabetic patients, especially those with diabetic neuropathy. 
According to Sanz et al. [8], in patients with Alzheimer’s disease and diabetes, difficulties in 
performing activities of daily living which are known to cause functional decline are part of the 
symptoms found in these patients. 
However, empowerment programmes that rely on the use of structured education approaches such 
as Diabetes Education and Self Management for Ongoing and Newly Diagnosed  (DESMOND),  
X-pert and Dose Adjustment for Normal Eating (DAFNE) that incorporate lifestyle changes in the 
management of diabetes could help ameliorate some of these challenges [41–43]. 
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5. Conclusions 
The prevalence of diabetes and dementia is on the increase in the UK and worldwide partly due to 
the increase in the ageing population and lifestyle choices. In addition, there is evidence of the 
association between diabetes, dementia and cognitive decline including the shared pathogenesis 
between diabetes and Alzheimer’s disease. 
This review has also shown that diabetes is a risk factor for dementia and cognitive decline. 
Conversely, cognitive impairment and dementia have a significant impact on self-management of 
diabetes. In particular, hyperglycaemia and hypoglycaemia may result from poor self management of 
diabetes due to a decline in cognitive function further increasing the risk of diabetic complications. 
The association between diabetes, cognitive decline and dementia appears bidirectional and this could 
lead to a vicious cycle. Further studies are required to fully establish the link between diabetes, 
dementia and cognitive decline. 
Relevance to Clinical Practice 
Patients with diabetes who have dementia may benefit from structured education programmes such 
as DESMOND and DAFNE. Lifestyle approaches have been found to be effective in reducing the risk 
of developing type 2 diabetes and this is essential in the prevention and management of dementia due 
to the lack of effective treatment options for this condition [1,9]. This should reduce a deterioration in 
cognitive decline and enhance self-management of diabetes. In addition, the recognition of cognitive 
decline should bring into focus the need for education strategies. 
Peripheral insulin administration as the only strategy for managing diabetic patients with 
Alzheimer’s disease may increase the risk of hypoglycaemia and hyperinsulinaemia in these patients. 
Therefore, the use of intranasal insulin which is absorbed directly to the central nervous system 
provides additional option. Due to the possible link between hypoglycaemia and dementia, it is useful 
to balance the need for treatment with insulin and sulphonylureas and the risk of developing 
hypoglycaemia in patients who have diabetes and dementia. 
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